Victoria A. Feher
Global Head, Applications Science and Modeling Services
Schrodinger, Inc.
Schrödinger, Inc. is an industry leader for innovative computational chemistry software solutions in small molecule drug discovery, biologics and material sciences. Victoria Feher heads a group of over 30 scientists who provide expertise for Schrödinger’s software customers, research collaborations and contract drug discovery consulting with pharmaceutical industry partners. Originally trained in the fields of biophysics and biochemistry, Victoria has applied her broad background over the last 20 years as a computational modeler at Takeda Pharmaceuticals , Quorex Pharmaceuticals, and as Assistant Director for the Center of Drug Discovery Innovation at the University of California, San Diego. She has over 30 peer-reviewed publications and is co-inventor on numerous patents including TAK659, an oncology drug currently in Phase II clinical trials.
Presentation(s):
-
Free energy perturbation calculations as a computational assay for structure based drug design
Wednesday, February 7
11:00 AM – 11:30 AM